Blueshift Asset Management, LLC Natera, Inc. Transaction History

Blueshift Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$86.26 - $119.0 $989,488 - $1.37 Million	-11,471 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$100.17 - $126.36 $901,429 - $1.14 Million	8,999 Added 364.04%	11,471 $1.28 Million
Q2 2021 Aug 13, 2021	BUY	$86.05 - $119.72 $212,715 - $295,947	2,472 New	2,472 $281,000
Q1 2021 May 06, 2021	SELL	$91.47 - $124.36 $212,301 - $288,639	-2,321 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$66.66 - $111.74 $154,717 - $259,348	2,321 New	2,321 $231,000

528

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Blueshift Asset Management, LLC with notifications on news.